1h Free Analyst Time
The cancer diagnostics market is forecasted to grow by USD 17.74 billion during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the cancer diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of cancer, demand for personalized medicines, and need for cost-cutting in drug discovery and development.
The cancer diagnostics market is segmented as below:
By End-user
- Hospitals and clinics
- Diagnostic laboratories
By Type
- IVD
- Imaging
- LDT
By Geographical Landscape
- North America
- Europe
- APAC
- Rest of World (ROW)
The report on the cancer diagnostics market covers the following areas:
- Cancer diagnostics market sizing
- Cancer diagnostics market forecast
- Cancer diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global Cancer diagnostics market: Abbott Laboratories, Agilent Technologies Inc., Astellas Pharma Inc., Becton Dickinson and Co., bioMerieux SA, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., General Electric Co., GlaxoSmithKline PLC, Hologic Inc., Illumina Inc., Merck KGaA, Myriad Genetics Inc., Novartis AG, Pfizer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in R&D and advances in technology."
According to the report, one of the major drivers for this market is the high prevalence of Cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Astellas Pharma Inc.
- Becton Dickinson and Co.
- bioMerieux SA
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- General Electric Co.
- GlaxoSmithKline Plc
- Hologic Inc.
- Illumina Inc.
- Merck KGaA
- Myriad Genetics Inc.
- Novartis AG
- Pfizer Inc.
- QIAGEN NV
- Quest Diagnostics Inc.
- Siemens AG
- Thermo Fisher Scientific Inc.
